AIM: To access the frequency and level of apoptotic CD34+ cells isolated from the marrow fluid of patients with post-hepatitis cirrhosis. METHODS: The frequency of bone marrow CD34+ cells and apoptotic bone marrow CD34+ cells in 31 in-patients with post-hepatitis cirrhosis (cirrhosis group), and 15 out-patients without liver or blood disorders (control group) was calculated by flow cytometry. Parameters were collected to evaluate liver functions of patients in cirrhosis group. RESULTS: The percentage of normal bone marrow CD34+ cells was 6.30% ± 2.48% and 1.87% ± 0.53% (t = 3.906, P < 0.01) while that of apoptotic marrow CD34+ cells was 15.00% ± 15.81% and 5.73% ± 1.57% (t = 2.367, P < 0.05) in cirrhosis and control groups, respectively. The percentage of apoptotic marrow CD34+ cells was 6.25% ± 3.30% and 20.92 ± 18.5% (t = 2.409, P < 0.05) in Child-Pugh A and Child-Pugh B + C cirrhotic patients, respectively. The percentage of late apoptotic marrow CD34+ cells was positively correlated with the total bilirubin and aspartate aminotransferase serum levels in patients with cirrhosis. CONCLUSION: The status of CD34+ marrow cells in cirrhotic patients may suggest that the ability of hematopoietic progenitor cells to transform into mature blood cells is impaired.
AIM: To access the frequency and level of apoptotic CD34+ cells isolated from the marrow fluid of patients with post-hepatitis cirrhosis. METHODS: The frequency of bone marrow CD34+ cells and apoptotic bone marrow CD34+ cells in 31 in-patients with post-hepatitis cirrhosis (cirrhosis group), and 15 out-patients without liver or blood disorders (control group) was calculated by flow cytometry. Parameters were collected to evaluate liver functions of patients in cirrhosis group. RESULTS: The percentage of normal bone marrow CD34+ cells was 6.30% ± 2.48% and 1.87% ± 0.53% (t = 3.906, P < 0.01) while that of apoptotic marrow CD34+ cells was 15.00% ± 15.81% and 5.73% ± 1.57% (t = 2.367, P < 0.05) in cirrhosis and control groups, respectively. The percentage of apoptotic marrow CD34+ cells was 6.25% ± 3.30% and 20.92 ± 18.5% (t = 2.409, P < 0.05) in Child-Pugh A and Child-Pugh B + C cirrhotic patients, respectively. The percentage of late apoptotic marrow CD34+ cells was positively correlated with the total bilirubin and aspartate aminotransferase serum levels in patients with cirrhosis. CONCLUSION: The status of CD34+ marrow cells in cirrhotic patients may suggest that the ability of hematopoietic progenitor cells to transform into mature blood cells is impaired.
Authors: James Geller; Istvan Petak; Kinga Szekely Szucs; Katalin Nagy; David M Tillman; Janet A Houghton Journal: Clin Cancer Res Date: 2003-12-15 Impact factor: 12.531
Authors: Faris Q Alenzi; Saleh M Al-Ghamdi; Waleed G Tamimi; Abdulaziz M Al-Sebiany; Iman M El-Nashar; Iman El-Tounsi; Mohammad S Bamaga; Maher M Al-Enazi; Ali S Al-Amri; Iman H Al-Sheikh Journal: Yale J Biol Med Date: 2005-01
Authors: Dael Geft; Shmuel Schwartzenberg; Ori Rogowsky; Ariel Finkelstein; Jacob Ablin; Sofia Maysel-Auslender; Dov Wexler; Gad Keren; Jacob George Journal: PLoS One Date: 2008-09-18 Impact factor: 3.240
Authors: Bruno Diaz Paredes; Lanuza Alaby Pinheiro Faccioli; Luiz Fernando Quintanilha; Karina Dutra Asensi; Camila Zaverucha do Valle; Paulo César Canary; Christina Maeda Takiya; Antonio Carlos Campos de Carvalho; Regina Coeli Dos Santos Goldenberg Journal: World J Hepatol Date: 2012-10-27